Synthesis and the antimicrobial activity of metalcarbene compounds of the triazole series
DOI:
https://doi.org/10.24959/ophcj.14.793Keywords:
metalcarbene compounds, antimicrobial activityAbstract
Мetalcarbene compounds of a series of [1,2,4] and [1,2,3]triazoles have been synthesized to study their antimicrobial activity. Monocarbene complexes of palladium (9a) and copper(I) (9b,12,15), biscarbene complexes of palladium (4a) and copper(I) (4b,14), a carbenoid complex of cobalt (5) have been synthesized by the direct interaction of stable carbenes with transition metal salts or by analogous in situ reactions. The intermediate sterically hindered carbenes – [1,2,4]triazol-5-ylidenes 3a-c have been isolated in the individual state. Being intermediate in the synthesis of mesoionic complexes 9a,b 1-adamantyl-4-phenyl-[1,2,3]triazole has been synthesized by [3+2]-cycloaddition of 1-adamantylazide to phenylacetylene in the presence of the biscarbene complex of copper(I) iodide 14. Characteristic signals of the carbenoid carbon atoms are detected in the 13С NMR spectra of complexes in the range of 165-203 ppm. A high antimicrobial activity has been found for complexes 5.12; for compound 12 it corresponds to the minimal bacteriostatic concentration (MBsC) 15.6 mkG/mL, the minimal bactericidal concentration (MBcC) 31.2 mkG/mL (М. luteum), and MBsC 31.2 mkG/mL, MBcC 62.5 mkG/mL (S. aureus). The highest activity in the series studied is observed for the carbenoid complex of cobalt (5) on the test-culture of M. luteum (MBsC 15.6 mkG/mL and MBcC 31.2 mkG/mL), and on the test-culture of C. tenuis (the minimal fungistatic concentration is 7.8 mkG/mL and the minimal fungicidal concentration is 31.2 mkG/mL).Downloads
References
- Marichev К.A., Glinyanaya N.V., Korotkikh N.І., Shvaika О.P., Kiselyov А.V., Knishevitsky А.V., Pekhtereva Т.М., Dudarenko G.V., Komarovska-Porokhnyavets О.P., Novikov V.P., Lubenets V.І. Zhurnal organichnoi ta farmatsevtichnoi khimii – Journal of organic and pharmaceutical chemistry, 2011, Vol. 9, No.3(35), pp.72-79.
- Korotkikh N.І., Shvaika О.P., Kiselyov А.V., Knishevitsky А.V., Glinyanaya N.V., Marichev К.A., Novikov V.P., Lubenets V.І., Iskiv О.P., Moskalenko N.I., Komarovska-Porokhnyavets О.P. Visnyk natsionalnogo universitetu „Lvivska polytekhnika” – Herald of National University “Lvivska polytekhnika”, 2008, No.622, pp.3-6.
- Liu L., Huang Y., Riduan S.N., Gao S., Yang Y., Fan W., Zhang Y. Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent. Biomaterials, 2012, 33, pp.8625-8631. Cited 4 times. DOI: http://dx.doi.org/10.1016/j.biomaterials.2012.08.006
- Che C.-M., Sun R.W.-Y. Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment. Chem. Commun., 2011, 47, pp. 9554-9560. Cited 37 times. DOI: 10.1039/c1cc10860c
- Oehninger L., Rubbiani R., Ott I. N-Heterocyclic carbene metal complexes in medicinal chemistry. Dalton Trans., 2013, 42, pp.3269-3284. Cited 29 times. DOI:10.1039/c2dt32617e
- Gasser G., Metzler-Nolte N. The potential of organometallic complexes in medicinal chemistry. Cur. Opinion Chem. Biol., 2012, Vol. 16, pp.84-91. Cited 45 times. DOI: 10.1016/j.cbpa.2012.01.013
- Liu W., Gust R. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs. Chem. Soc. Rev., 2013, Vol. 42, 755. Cited 36 times. DOI: 10.1039/c2cs35314h
- John A., Ghosh P. Fascinating frontiers of N/O-functionalized N-heterocyclic carbene chemistry: from chemical catalysis to biomedical applications. Dalton Trans., 2010, 39, pp.7183-7206. Cited 61 times. DOI: 10.1039/c002475a
- Hemmert C., Fabie A., Fabre A., Benoit-Vical F., Gornitzka H. Synthesis, structures, and antimalarial activities of some silver(I), gold(I) and gold(III) complexes involving N-heterocyclic carbene ligands. Eur. J. Med. Chem., 2013, 60, pp.64-75. Cited 3 times. DOI: http://dx.doi.org/10.1016/j. ejmech.2012.11.038
- Weaver J., Gaillard S., Toye C., Macpherson S., Nolan S.P., Riches A. Cytotoxicity of Gold(I) N-Heterocyclic Carbene Complexes Assessed by Using Human Tumor Cell Lines. Chem. Eur. J., 2011, 17, pp.6620-6624. Cited 23 times.
- DOI: http://dx.doi.org/10.1016/j.ejmech.2012.11.038
- Yan J., Chow A.L.-F., Leung C.-H., Sun R.W.-Y., Ma D.-L., Che C.-M. Cyclometalated gold(III) complexes with N-heterocyclic carbene ligands as topoisomerase I poisons. Chem. Commun., 2010, 46, pp.3893-3895. Cited 36 times. DOI: 10.1039/c001216e
- Korotkikh N.I., Saberov V.Sh., Kiselev A.V., Glinyanaya N.V., Marichev K.A., Pekhtereva T.M., Dudarenko G.V., Bumagin N.A., Shvaika O.P. Heterocyclic carbene complexes of nickel, palladium, and copper(I) as effective catalysts for the reduction of ketones. Chemistry of Heterocyclic Compounds, 2012, 47, pp.1551-1560. Cited 0 times. DOI: 10.1007/s10593-012-0947-9
- Korotkikh N.I., Kiselev A.V., Knishevitsky A.V., Rayenko G.F., Pekhtereva T.M., Shvaika O.P. Recyclization of 1,3,4-oxadiazoles and bis-1,3,4-oxadiazoles into 1,2,4-triazole derivatives. Synthesis of 5-unsubstituted 1,2,4-triazoles. Chemistry of Heterocyclic compounds, 2005, 7, pp.1026-1032. Cited 2 times. DOI: 10.1007/s10593-005-0240-2
- Korotkikh N.І., Cowley А.H., Moore J.А., Glinyanaya N.V., Panov І.S., Rayenko G.F., Pekhtereva T.М., Shvaika О.P. Reaction of 1-tert-butyl-3,4-diphenyl-1,2,4-triazol-5-ylidenes with a malonic ester. Org. Biomol. Chem., 2008, 1, pp.195-199. Cited 5 times. DOI: 10.1039/b712885a.
- Chen X., Liu R., Xu Y., Zou G. Tunable protic ionic liquids as solvent-catalysts for improved synthesis of multiply substituted 1,2,4-triazoles from oxadiazoles and organoamines. Tetrahedron, 2012, 68, pp.4813-4819. DOI: 0.1016/j.tet.2012.03.114
- Order of the Ukrainian Education and Science Ministry №167 from 05.04.2007 Novosti mediciny i farmacii – News of medicine and pharmacy, 2008, 236, pp.2-4.
- Labinskaya А.S. Microbiology with appliances of microbiological studies. – М.: Medicine, 1972, pp.84-93.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).